Dr. Koneru is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
2651 Discovery parkway
Bloomington, IN 47408Phone+1 812-918-5052Fax+1 812-918-5914- Is this information wrong?
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 1991 - 1993
SUNY Health Science Center at BrooklynResidency, Internal Medicine, 1987 - 1990
Osmania Medical College NTR UHSClass of 1982
Certifications & Licensure
IN State Medical License 1996 - 2025
IL State Medical License 1994 - 1999
MD State Medical License 1991 - 1994
NJ State Medical License 1988 - 1991- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
- Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Start of enrollment: 2008 Jan 01
- Fludarabine, Velcade and Rituximab for Relapsed or Refractory Follicular Non-Hodgkin Lymphoma Start of enrollment: 2010 Oct 01
- First-line Everolimus +/- Paclitaxel for Cisplatin-ineligible Patients With Advanced Urothelial Carcinoma Start of enrollment: 2010 Dec 01
Publications & Presentations
PubMed
- 2 citationsPhase I Study of Amrubicin and Cyclophosphamide in Patients With Advanced Solid Organ Malignancies: HOG LUN 07-130.Shadia I. Jalal, Nasser H. Hanna, Robin Zon, Gregory A. Masters, Hossein Borghaei, Karuna Koneru, Sunil Badve, Nagendra K A Prasad, Neeta Somaiah, Jingwei Wu, Zhangshe...> ;American Journal of Clinical Oncology. 2017 Aug 1
- 22 citationsSunitinib Plus Paclitaxel in Patients with Advanced Esophageal Cancer: A Phase II Study from the Hoosier Oncology GroupeJordan Schmitt, Scott R. Sommers, William E. Fisher, Rafat Ansari, Erwin Robin, Karuna Koneru, John McClean, Ziyue Liu, Yan Tong, Nasser H. Hanna> ;Journal of Thoracic Oncology. 2012 Apr 1
- Sunitinib plus paclitaxel in patients with advanced esophageal cancer: A phase II study from the Hoosier Oncology Group.Schmitt JM, Sommers SR, Fisher WB, Ansari RH, Robin EL, Koneru K, McClean JW, Liu Z, Hanna NH> ;J. Clin. Oncol.. 2011-05-20
- Join now to see all
Professional Memberships
- Member
Hospital Affiliations
Indiana University Health Bedford HospitalBedford, Indiana
Indiana University Health Bloomington HospitalBloomington, Indiana
Indiana University Health University HospitalIndianapolis, Indiana
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
